|
|
 |
|
Viewing report
|
|
|
|
Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review
GlobalData, April 2011, Pages: 55
Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review
Summary
Bayer AG (Bayer) engages in the development, production, and marketing of health care, nutrition and high-tech materials. Operating as the management holding company for the Bayer Group, the company’s business operations are classified into three subgroups, namely Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. Operating through 350 companies worldwide, the company markets about 5,000 products, to benefit people and improve their quality of life. Major products offered by the company include, ethical pharmaceuticals and other healthcare products, polymers and agricultural products. Bayer and its subsidiaries have operations in Europe, North America, Latin America, Asia Pacific, Africa, and the Middle East. Recently, the company amended its existing collaboration with Mendel Biotechnology, Inc., by entering into a new three-year collaboration agreement, for higher yields and improved stress tolerance in crops. Also, the company, through Bayer MaterialScience, formed technical collaboration with Mitsubishi Heavy Industries Plastic Technology Co., Ltd. and Kyowa Industrial Co., Ltd., for the use of PC glazing in the Japanese automotive industry. Additionally, in recent dates, Ehrfeld Mikrotechnik BTS, a Bayer Technology Services company, inked a worldwide manufacturing and distribution license agreement with Lonza, to exclusively manufacture and market Lonza microreactors; and Bayer MaterialScience inked a strategic partnership agreement with Masdar, a wholly-owned subsidiary of the Mubadala Development Company, for the proposed construction of an EcoCommercial Building prototype in Masdar City, Abu Dhabi. The company is headquartered in Leverkusen, Germany.
Bayer AG Key Recent Developments…
Feb 17, 2011: Bayer Starts Pilot Plant For Plastic Manufacturing With CO2
Dec 09, 2010: Bayer To Significantly Expand Capacities In China
Oct 28, 2010: Bayer Reports Net Income Of EUR280 Million For Q3 2010
Mar 25, 2010: Health Canada Approves Bayer Contour USB Blood Glucose Meter
Mar 18, 2010: Global Partners Collaborate To Speed Development Of New TB Drug Combinations
This comprehensive SWOT profile of Bayer AG provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Bayer AG Petrochemicals Capacity and SWOT Analysis
Bayer HealthCare AG - Strategic SWOT Analysis Review
Hikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review
Bayer Schering Pharma AG: PharmaVitae Profile
Menarini Group - Strategic SWOT Analysis Review
Bayer HealthCare Pharmaceuticals - Strategic SWOT Analysis Review
Bachem AG (BAND) - Financial and Strategic SWOT Analysis Review
Cytos Biotechnology AG (CYTN) - Financial and Strategic SWOT Analysis Review
MediGene AG (MDG) - Financial and Strategic SWOT Analysis Review
Bayer HealthCare AG Market Share Analysis
|
|
|
|
